Envista (NVST) Projected to Post Earnings on Thursday

Envista (NYSE:NVST) is expected to release its Q3 2025 results after the market closes on Thursday, October 30th. Analysts expect Envista to post earnings of $0.27 per share and revenue of $639.4920 million for the quarter. Envista has set its FY 2025 guidance at 1.050-1.15 EPS.Interested persons can find conference call details on the company’s upcoming Q3 2025 earningreport page for the latest details on the call scheduled for Thursday, October 30, 2025 at 5:00 PM ET.

Envista (NYSE:NVST) last released its quarterly earnings data on Thursday, July 31st. The company reported $0.26 earnings per share for the quarter, topping the consensus estimate of $0.24 by $0.02. Envista had a net margin of 2.11% and a return on equity of 4.84%. The firm had revenue of $682.10 million for the quarter, compared to analyst estimates of $638.21 million. During the same quarter in the prior year, the business earned $0.11 earnings per share. Envista’s quarterly revenue was up 7.7% on a year-over-year basis. On average, analysts expect Envista to post $1 EPS for the current fiscal year and $1 EPS for the next fiscal year.

Envista Price Performance

Shares of NYSE:NVST opened at $20.38 on Tuesday. The firm’s 50 day moving average is $20.58 and its two-hundred day moving average is $19.26. Envista has a 52 week low of $14.22 and a 52 week high of $23.00. The firm has a market capitalization of $3.39 billion, a P/E ratio of 63.67, a PEG ratio of 1.09 and a beta of 1.01. The company has a current ratio of 2.44, a quick ratio of 2.08 and a debt-to-equity ratio of 0.46.

Institutional Inflows and Outflows

Hedge funds have recently added to or reduced their stakes in the business. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. grew its position in Envista by 73.1% in the second quarter. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. now owns 2,248 shares of the company’s stock worth $44,000 after buying an additional 949 shares during the last quarter. EverSource Wealth Advisors LLC grew its position in Envista by 378.0% in the second quarter. EverSource Wealth Advisors LLC now owns 2,414 shares of the company’s stock worth $47,000 after buying an additional 1,909 shares during the last quarter. Captrust Financial Advisors grew its position in Envista by 38.4% in the second quarter. Captrust Financial Advisors now owns 15,465 shares of the company’s stock worth $302,000 after buying an additional 4,290 shares during the last quarter. Arrowstreet Capital Limited Partnership acquired a new position in Envista in the second quarter worth approximately $318,000. Finally, Prudential Financial Inc. grew its position in Envista by 22.1% in the second quarter. Prudential Financial Inc. now owns 18,785 shares of the company’s stock worth $367,000 after buying an additional 3,395 shares during the last quarter.

Analysts Set New Price Targets

NVST has been the topic of several analyst reports. Stifel Nicolaus raised their price target on shares of Envista from $24.00 to $25.00 and gave the company a “buy” rating in a research note on Friday, August 1st. Evercore ISI set a $25.00 price target on shares of Envista in a research note on Wednesday, October 8th. Weiss Ratings restated a “sell (d)” rating on shares of Envista in a research note on Wednesday, October 8th. Wells Fargo & Company raised their price target on shares of Envista from $17.00 to $19.00 and gave the company an “equal weight” rating in a research note on Friday, August 1st. Finally, Morgan Stanley increased their price objective on shares of Envista from $16.00 to $17.00 and gave the company an “equal weight” rating in a report on Friday, August 1st. One analyst has rated the stock with a Strong Buy rating, four have given a Buy rating, ten have assigned a Hold rating and two have assigned a Sell rating to the company’s stock. According to data from MarketBeat.com, the company currently has a consensus rating of “Hold” and an average price target of $21.08.

Envista Company Profile

Envista Holdings Corporation, together with its subsidiaries, develops, manufactures, markets, and sells dental products in the United States, China, and internationally. The company operates in two segments, Specialty Products & Technologies, and Equipment & Consumables. The Specialty Products & Technologies segment offers dental implant systems, guided surgery systems, biomaterials, and prefabricated and custom-built prosthetics to oral surgeons, prosthodontists and periodontists, and general dentist; and brackets and wires, tubes and bands, archwires, clear aligners, digital orthodontic treatments, retainers, and other orthodontic laboratory products.